In three trials of Eli Lilly's Ixekizumab, the drug shows effectiveness in clearing plaque psoriasis. This autoimmune skin disease is hard to treat and can alter one's work productivity.
Eli Lilly's Ixekizumab Shows Promise As Treatment For Patients With Plaque Psoriasis
Tech Times - 8 Mar 2016 15:52
In three trials of Eli Lilly's Ixekizumab, the drug shows effectiveness in clearing plaque psoriasis. This autoimmune skin disease is hard to treat and can alter one's work productivity.
Share this Article
Recommended